Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
Accessnewswire· 2025-12-19 14:00
® [1] HAMILTON, BERMUDA / ACCESS Newswire / December 19, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and supplying nucleic acid delivery technology for partners in biotech and pharma, today announced that its associate company Altamira Medica ("Medica") has obtained marketing approval from the National Medical Products Administration (NMPA) of China for its Bentrio nasal spray in allergic rhinitis. The clearance will allow Nuance Pharma, M ...
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of James Hardie Industries plc. (JHX) Shareholders
Prnewswire· 2025-12-19 14:00
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in James Hardie Industries plc. ("James Hardie Industries plc." or the "Company") (NYSE: JHX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of James Hardie Industries plc. investors who were adversely affected by alleged securities fraud between May 20, 2025 and August 18, 2025. Follow the link below to get more information and be contacted by a member of our team: https: ...
Levi & Korsinsky Notifies Shareholders of Avantor, Inc. (AVTR) of a Class Action Lawsuit and an Upcoming Deadline
Prnewswire· 2025-12-19 14:00
Core Points - A class action securities lawsuit has been filed against Avantor, Inc. for alleged securities fraud affecting investors between March 5, 2024, and October 28, 2025 [1][2] - The lawsuit claims that Avantor's competitive positioning was misrepresented, indicating that the company was facing negative impacts from increased competition [2] - Investors who suffered losses during the specified period have until December 29, 2025, to request to be appointed as lead plaintiff [3] Company Details - The complaint alleges that the defendants made false statements regarding Avantor's business operations and prospects, which were materially misleading [2] - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]
Blue Owl Capital: Follow The Insiders And Load Up (NYSE:OBDC)
Seeking Alpha· 2025-12-19 14:00
Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall Investing ! There is a free trial and a special discount of 10% for you. Join us today!Daniel Sereda is chief investment analyst at a family office whose investments span continents and diverse asset classes. This requires him to navigate through a plethora of information on a daily basis. His expertise is in filtering this wealth of data to extract t ...
Levi & Korsinsky Notifies DeFi Technologies Investors of a Class Action Lawsuit and Upcoming Deadline - DEFT
Prnewswire· 2025-12-19 14:00
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DeFi Technologies ("DeFi Technologies" or the "Company") (NASDAQ: DEFT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DeFi Technologies investors who were adversely affected by alleged securities fraud between May 12, 2025 and November 14, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/defi-techn ...
Perrigo Company plc Class Action: Levi & Korsinsky Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026 - PRGO
Prnewswire· 2025-12-19 14:00
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Perrigo Company plc ("Perrigo Company plc" or the "Company") (NYSE: PRGO) of a class action securities lawsuit. CONTACT: https://zlk.com/pslra-1/perrigo-company-plc-lawsuit-submission-form?prid=180851&wire=4 Levi & Korsinsky, LLP Joseph E. Levi, Esq. Ed Korsinsky, Esq. 33 Whitehall Street, 27th Floor New York, NY 10004 [email protected] Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.com PRGO investors may also contact Josep ...
Investors who lost money on Blue Owl Capital Inc. (OWL) should contact Levi & Korsinsky about pending Class Action - OWL
Prnewswire· 2025-12-19 14:00
NEW YORK , Dec. 19, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Blue Owl Capital Inc. ("Blue Owl Capital Inc." or the "Company") (NYSE: OWL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Blue Owl Capital Inc. investors who were adversely affected by alleged securities fraud between February 6, 2025 and November 16, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/psl ...
Ultimate Cannabis Asset (UCASU) to Expand "Best Performing Cannabis Portfolio" by 400% in 2026
Prnewswire· 2025-12-19 14:00
ATLANTA, Dec. 19, 2025 /PRNewswire/ -- UC Asset Limited Partnership (OTCQB: UCASU) today issued a statement applauding President' Trump's decision to rescheduling marijuana from Schedule I to Schedule III, which is a significant measure of deregulation for cannabis industry. UC Asset, which stands for Ultimate Cannabis Asset, is one of the only four US public companies devoted to investing in cannabis properties. Its management claims to have built the "best performing" cannabis property portfolio among US ...
Shareholders of Synopsys, Inc. Should Contact Levi & Korsinsky Before December 30, 2025 to Discuss Your Rights - SNPS
Prnewswire· 2025-12-19 14:00
Core Viewpoint - A class action securities lawsuit has been filed against Synopsys, Inc. alleging securities fraud that negatively impacted investors between December 4, 2024, and September 9, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that the defendants made false statements and concealed information regarding the negative impact of the Company's focus on artificial intelligence customers on its Design IP business [2]. - It is alleged that certain decisions regarding the Company's roadmap and resources were unlikely to achieve their intended results, leading to a material negative impact on financial results [2]. - The lawsuit asserts that the defendants' positive statements about the Company's business and prospects were materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until December 30, 2025, to request to be appointed as lead plaintiff in the case [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].
Fundstrat Capital Announces Monthly Distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI)
Prnewswire· 2025-12-19 14:00
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- Fundstrat Capital today announced the following monthly distribution for the Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI). The Fundstrat Granny Shots US Large Cap & Income ETF (NYSE: GRNI) launched on November 18, 2025. GRNI pairs the equity holdings of the Fundstrat Granny Shots US Large Cap ETF (NYSE: GRNY) with an actively managed options overlay designed to generate income while maintaining exposure to long-term growth themes. Distribution Details ...